Women's Health News

RSS

Study explores relationship between traumatic early life events and gynecological cancer

An investigation that is published in the current issue of Psychotherapy and Psychosomatics explores the relationship between early life events and gynecological cancer.

29 Mar 2012

DSMB recommends Bionovo to continue Menerba Phase 3 trial for hot flashes

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that the Company's independent Data Safety Monitoring Board (DSMB) recommended that the Phase 3 trial of Menerba (MF101) could continue as designed after an initial review of its clinical safety and tolerability data.

29 Mar 2012

Amerigroup announces successful efforts at preventing premature births

Amerigroup Corporation announced its successful efforts at preventing premature births – as well its commitment to protecting access to affordable drug therapies for at-risk mothers – at the annual Norfolk/Virginia Beach March of Dimes kick-off breakfast for the March for Babies.

29 Mar 2012

IMRT associated with reduced toxicities when compared with standard whole breast irradiation

Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities, according to a study in Practical Radiation Oncology (PRO), the official clinical practice journal of the American Society for Radiation Oncology (ASTRO).

29 Mar 2012

Protein's location in a cell affects impact on disease

If the fight against breast cancer were a criminal investigation, then the proteins survivin, HDAC6, CBP, and CRM1 would be among the shadier figures. In that vein, a study to be published in the March 30 Journal of Biological Chemistry is the police report that reveals a key moment for keeping cancer cells alive: survivin's jailbreak from the nucleus, aided and abetted by the other proteins.

29 Mar 2012

A third of UK babies born this year could live to be 100

According to figures from the Office for National Statistics, the number of centenarians could increase by more than sevenfold by 2035. One in three babies born in the UK this year will live to 100 says the report.

28 Mar 2012

New MRI method to test effectiveness of baking soda against breast cancer

A University of Arizona study that looks to improve the way doctors can measure the effectiveness of drinking baking soda to fight breast cancer has received a $2 million grant from the National Institutes of Health.

28 Mar 2012

Study: Some breast cancer tumours may not respond to taxane chemotherapy

Some breast cancer tumours may be resistant to a common chemotherapy treatment, suggests recent medical research at the University of Alberta.

28 Mar 2012

Olaparib improves survival rates in platinum-sensitive relapsed serous ovarian cancer

Today at the Society of Gynecologic Oncology (SGO) 43rd Annual Meeting on Women's Cancer®, Dr. Jonathan Ledermann, Director of Cancer Services and Professor of Medical Oncology at University College London, presented new data updating the overall survival of women enrolled in a "Phase II randomized placebo-controlled study of olaparib (AZD2281) maintenance in patients with platinum-sensitive relapsed serous ovarian cancer."

28 Mar 2012

Scott Brown turns to Olympia Snowe for help in appealing to women voters

The Massachusetts senator, who has riled some women's groups for his stand on the Obama administration's contraception coverage policy, is seeking to raise the profile of women in his campaign.

28 Mar 2012

Placentophagia may offer benefits to human mothers

A paper by neuroscientists at the University at Buffalo and Buffalo State College suggests that ingestion of components of afterbirth or placenta -- placentophagia -- may offer benefits to human mothers and perhaps to non-mothers and males.

28 Mar 2012

ECTS, IOF publish guidance document to manage GIO

Oral glucocorticoids are commonly prescribed for a wide variety of disorders, most commonly for rheumatoid arthritis, obstructive pulmonary disease and inflammatory bowel diseases. However, the use of these medications can result in rapid bone loss during the first three to six months of therapy, leading to increased risk of fragility fractures.

28 Mar 2012

Study: 20.1M individuals infected with HEV across 9 world regions

New research funded by the World Health Organization (WHO) estimates that 20.1 million individuals were infected with hepatitis E virus (HEV) genotypes 1 and 2 across 9 world regions in 2005.

28 Mar 2012

Roundup: Abortion-restriction bills stopped in Ga.; Minnesota can cut health care aide pay; Guidelines for Ore. coordinated care released

One of the most controversial bills this legislative session, that sought to put new restrictions on late-term abortions, was all but gutted Monday after a bipartisan coalition in the state Senate forced key changes. The original proposal would have cut by about six weeks the time women in Georgia may have an elective abortion. With the changes, it would now also include an exemption for "medically futile" pregnancies, giving doctors the option to perform an abortion when a fetus has congenital or chromosomal defects. The change hits at the heart of the controversy: Should fetuses once they hit 20 weeks be protected even if those protections mean women are forced to continue medically risky pregnancies?

28 Mar 2012

Diet guru Pierre Dukan to face ethical hearing

Dr. Pierre Dukan, the founder of the controversial Dukan Diet now faces an ethics hearing after suggesting children could pass a new exam by staying thin. His diet, said to be followed by some celebrities, recommends avoiding starch and carbohydrates. Some nutritionists say it can be dangerous. Dr Jean-Michel Cohen said the protein-rich diet could cause heart disease and breast cancer.

27 Mar 2012

Morning after pills difficult for teenagers to procure

Quite a few U.S. pharmacies may give teen girls incorrect information over the phone about whether they can get the morning-after pill. The pill is a form of emergency contraception taken within 72 hours after unprotected sex to prevent pregnancy without a prescription, a new study suggests.

27 Mar 2012

Boniva generics receive FDA approval for treatment, prevention of osteoporosis

The U.S. Food and Drug Administration today approved the first generic versions of Boniva (ibandronate) tablets, a once-monthly product to treat or prevent osteoporosis in women after menopause.

27 Mar 2012

U.S. has ability to help curb effects of HIV among women at home, abroad

The U.S. has "been working toward integrating HIV, sexual and reproductive health, and gender-based violence services for women overseas," and "[i]t's time we did the same at home," Serra Sippel, president of the Center for Health and Gender Equity, writes in this Huffington Post "Impact" blog post.

27 Mar 2012

Sientra receives FDA approval for new silicone gel-filled breast implant

Today, the U.S. Food and Drug Administration approved a silicone gel-filled breast implant manufactured by Sientra Inc. to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age.

27 Mar 2012

Promotion and education of female condom prevent HIV and save medical care costs

A new economic analysis, conducted by Johns Hopkins Bloomberg School of Public Health and featured in the current issue of Springer's journal AIDS and Behavior, showed that the DC Female Condom program, a public-private partnership to provide and promote female condoms, prevented enough HIV infections in the first year alone to save over $8 million in future medical care costs.

27 Mar 2012